Natasha A. Jain

The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches

Natasha A. Jain, Kit Lu, Sawa Ito et al. · Cytotherapy · 2014 · 66 citations

Cell Therapy, Financial Burden, Transplantation +10

A multigene array for measurable residual disease detection in AML patients undergoing SCT

Meghali Goswami, Katherine S. McGowan, Kit Lu et al. · Bone Marrow Transplantation · 2015 · 35 citations · Full text

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events

Priyanka A. Pophali, Jeffrey K. Klotz, Sawa Ito et al. · Experimental Hematology · 2013 · 26 citations · Full text

Heart Failure, Transplantation, Marrow Transplantation +13

Treatment of refractory delayed onset heparin‐induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG)

Kimberley Doucette, Christin B. DeStefano, Natasha A. Jain et al. · Research and Practice in Thrombosis and Haemostasis · 2017 · 23 citations · Full text

Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors

Prathima Anandi, Natasha A. Jain, Xin Tian et al. · Bone Marrow Transplantation · 2016 · 21 citations · Full text

Transplantation, Marrow Transplantation, Stem Cell Transplantation +9